Search Results for 'clearflow'
-
Cardiovascular
Trial Data Show PleuraFlow Enables Improved Quality and Cost of Care for Cardiac Patients
Reduction of patient complications and hospital resource utilization after heart surgery demonstrated with the use of the PleuraFlow ACT System.Business Wire 01.15.20
-
R&D & Design
Designing from Finish to Start
When developing products for a value-based environment, it can be helpful to consider the end result first.Steve Maylish and Vicki Caiati 05.03.18
-
ClearFlow Expands Distribution of PleuraFlow System for Pediatric Cardiothoracic Surgery
Decision follows a successful limited market release in the United States, Germany, Switzerland, and the United Kingdom.Business Wire 08.04.17
-
ClearFlow Receives FDA Clearance for FlowGlide Technology for Cardiac Surgery Patients
The FlowGlide System is the next generation of ClearFlow’s Active Clearance Technology.Business Wire 07.12.17
-
Cardiovascular | Surgical
FDA Clears System that Reduces Chest Tube Occlusion Risk
Prevents or reduces chest drains from occluding with clot, which can lead to retained blood around the heart and lungs.Business Wire 06.21.17
-
Cardiovascular
ClearFlow Receives Frost & Sullivan ‘New Product Innovation’ Award for PleuraFlow Technology
Device is the only FDA-cleared product that enables caregivers to proactively prevent or minimize chest tube occlusions.Business Wire 04.24.17
-
Cardiovascular
All Patients at Risk of Retained Blood Syndrome After Heart Surgery, New Study Reveals
Drainage catheters have a high failure rate, data indicates.Business Wire 02.06.17
-
Cardiovascular
PleuraFlow Technology From ClearFlow Given High Marks in Study
Data show a marked reduction in retained blood syndrome and postoperative atrial fibrillation.ClearFlow Inc. 03.14.16
-
ClearFlow Announces Trial Results for Reduction of Complications After Heart Surgery
Study evaluated use of PleuraFlow Active Clearance Technology System to prevent retained blood complications.02.02.15
